Niamh McGuinness is Director of Pharma Solutions with the Applied AI Science Team in IQVIA. Niamh leads a diverse group of experts who build AI solutions and utilize a suite of award-winning technology to help pharma customers protect participant privacy and surface critical insights from unstructured data and literature, for a vast array use cases from bench to bedside, including R&D, drug safety and medical affairs. Niamh has been with IQVIA for 8 years. She received her PhD in neuroimmunology from Trinity College, Dublin.

Laura Dodd is the Director of Clinical Trial Transparency at Instem. Laura heads the DIA subgroup on EMA’s Policy 0043/FOIAs, which also covers redactions needed for Policy 0070 and Health Canada’s Public Release of Clinical Information. Laura started working in Data Sharing in 2014, which quickly required her to interact with many functional areas to obtain internal sponsor approval to share AND to fully protect both the intellectual property rights and protected personal data found in the documents. Prior positions include writing CSRs and submission summary documents for 20 years and coordinating research studies for industry, NIH, and the National Cancer Institute.

Jingyi is the one of the main drivers behind the data sharing and transparency initiatives at Lilly. He led the effort of data sharing through TransCelerate and worked closely with Vivli and ProjectDataSphere. In addition, he championed several projects to utilize the historical clinical trial data from TransCelerate to improve the efficiency of drug development. Jingyi has over 10 years of experience in the pharmaceutical industry across all stages of global clinical development of medical products, with extensive regulatory and submission related experience in different disease areas including oncology and autoimmune disease.